Rynek Aptek: – In 2018, we managed to obtain funding from external investors and from grants amounting to the total of 3 million PLN, so now we can conduct research on three products. The first one is used for tissue regeneration, and the second one is an anaesthetic product offering an accelerated and prolonged anaesthetic effect. Our plan also includes a preparation to be used in oncological diseases (…), says Paweł Biernat, Biotts CEO.
